We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnosis Errors Can Harm Patients

By HospiMedica staff writers
Posted on 13 Oct 2005
A new study reveals that procedures used to obtain and examine tissue for cancer diagnosis are prone to error that often results in harm to patients. More...
The findings are reported in the November 15, 2005, issue of Cancer.

A government-mandated error-detection method that involves the review of patient specimens, when patients have two or more specimens from the same body site, found that up to 12% of reviewed specimen pairs had an erroneous diagnosis. Pathologists failed to agree on the cause of most of these errors. Before this, the cause of errors in cancer diagnosis has not been well studied, due in part to the lack of national standards to detect errors.

Researchers at the University of Pittsburgh School of Medicine (PA, USA) reviewed tissue specimens, pathologists' findings, and medical records from four institutions that diagnose precancerous and cancerous lesions. They also reviewed patient material when the diagnoses differed on multiple tests from the same patient. They found that errors were relatively frequent and institution-dependent. Up to 9% of gynecologic specimen pairs (Pap test and cervical biopsy) contained an error and up to 12% of other specimen pairs contained an error. Institutional differences in error rates are probably related to bias in error reporting.

The majority of errors were a result of suboptimal specimen collection, while the proportion of errors caused by pathologist misinterpretation ranged from 5-50%. When pathologists reviewed specimens from other institutions, they frequently disagreed with the assignment of error cause. A review of medical records showed that gynecologic errors resulted in harm in 45% of cases, while other errors resulted in harm in 39% of cases. Pathologists also disagreed on the severity of harm caused by an error in cancer diagnosis.

According to the researchers, variability in practice impairs the ability to understand error cause. "The standardization and uniform reporting of errors in cancer diagnosis is the first step in improving safety,” concluded the authors.




Related Links:
U. of Pittsburgh

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.